• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝细胞癌经导管动脉栓塞术后血液凝固和纤维蛋白溶解的改变]

[Alteration of blood coagulation and fibrinolysis after transcatheter arterial embolization of hepatocellular carcinomas].

作者信息

Suyama Y, Iwai M, Fujii H, Miyoshi M

出版信息

Gan No Rinsho. 1985 May;31(5):518-21.

PMID:2991624
Abstract

Alteration in blood coagulation and fibrinolysis were observed serially after TAE 37 times by measuring PT, APTT, FDP, fibrinogen, AT III, plasminogen, and alpha 2-macroglobulin. Immediately after TAE, PT and APTT were prolonged, Fbg AT III, alpha 2-M, and platelets decreased, and FDP increased. These changes within 24 hours suggested that coagulation activities were accelerated, and fibrinolysis followed. Within four weeks after TAE, PT and APTT became most prolonged one to three days after, while AT III, Plg, and alpha 2-M became lowest on the third to seventh days. It is suggested that these decrease were mainly due to suppressed production resulting from damage of the residual liver.

摘要

通过测定PT、APTT、FDP、纤维蛋白原、抗凝血酶III(AT III)、纤溶酶原和α2-巨球蛋白,对37例TAE术后患者的血液凝固和纤维蛋白溶解情况进行了连续观察。TAE术后即刻,PT和APTT延长,纤维蛋白原、AT III、α2-M和血小板减少,FDP增加。这些24小时内的变化提示凝血活性加快,随后发生纤维蛋白溶解。TAE术后四周内,PT和APTT在术后1至3天延长至最长,而AT III、纤溶酶原和α2-M在第3至7天降至最低。提示这些降低主要是由于残余肝损伤导致生成受抑制。

相似文献

1
[Alteration of blood coagulation and fibrinolysis after transcatheter arterial embolization of hepatocellular carcinomas].[肝细胞癌经导管动脉栓塞术后血液凝固和纤维蛋白溶解的改变]
Gan No Rinsho. 1985 May;31(5):518-21.
2
[Alteration of blood coagulation and fibrinolysis after intra-arterial one-shot chemotherapy in liver cancer].[肝癌动脉内一次性化疗后血液凝固和纤维蛋白溶解的变化]
Gan No Rinsho. 1983 Aug;29(9):962-5.
3
Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.经导管肝动脉栓塞术对肝细胞癌患者凝血和纤溶的影响。
Am J Gastroenterol. 1991 Dec;86(12):1800-3.
4
[Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM)].经导管动脉栓塞术(TAE)联合可降解淀粉微球(DSM)治疗肝恶性肿瘤的疗效评估
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2653-8.
5
[The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2621-6.
6
Hepatic neoplasms: effects of transcatheter arterial embolization on coagulation and fibrinolysis.肝脏肿瘤:经导管动脉栓塞术对凝血和纤维蛋白溶解的影响
Radiology. 1990 Mar;174(3 Pt 1):747-50. doi: 10.1148/radiology.174.3.2154836.
7
[Ruptured hepatocellular carcinoma following transcatheter arterial embolization: a case report].经导管动脉栓塞术后肝细胞癌破裂:一例报告
Rinsho Hoshasen. 1986 Sep;31(9):1053-5.
8
[Transcatheter oily chemoemobolization of hepatocellular carcinoma using adriamycin, lipiodol and gelfoam: pharmacokinetics of adriamycin].
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):623-5.
9
[Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].剖宫产病例中凝血-纤溶系统及冷不溶性球蛋白的研究
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Oct;37(10):2049-58.
10
Transcatheter arterial embolization in unresectable hepatocellular carcinoma.
Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):135-9. doi: 10.1007/BF02575464.